Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

The Therapeutic Value Of Retinoic Acid In Chronic Discoid, Acute Guttate, And Erythrodermic Psoriasis: Clinical Observations On Twenty‐five Patients

S. Günther
Published 1973 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Twenty‐five patients with chronic discoid, acute guttate or erythrodermic psoriasis were treated with retinoic acid in various preparations, topical and oral, and the clinical response was observed for up to 3 months. Only four patients showed distinct clinical improvement. The possible side effects of topical retinoic acid therapy are mentioned.
This paper references



This paper is referenced by
10.1016/S0190-9622(94)70066-4
Response of psoriasis to a new topical retinoid, AGN 190168.
T. Esgleyes-Ribot (1994)
10.1080/109158197226892
Subchronic and Chronic Toxicity of Tazarotene Gel Following Topical Application in Hanford Miniswine
I. Ismail (1997)
10.1016/S0190-9622(81)70049-5
The therapeutic uses of topical vitamin A acid.
J. Thomas (1981)
10.1016/S0190-9622(97)80398-2
Tazarotene gel: efficacy and safety in plaque psoriasis.
G. Weinstein (1997)
10.1046/j.1365-2133.1999.140S54018.x
Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis
Gollnick (1999)
10.1007/978-3-642-68023-6_83
The Use of Oral Aromatic Retinoids in Psoriasis Therapy: an Overview of Past, Present, and Future Developments
E. Farber (1981)
10.2165/00003495-198734040-00003
The Retinoids
C. Orfanos (2012)
10.1007/978-1-4471-4432-8_7
Topical Therapy II: Retinoids, Immunomodulators, and Others
L. Guenther (2014)
Design, synthesis and biological evaluation of small molecules for controlling cellular development
Hesham Haffez (2016)
10.1111/j.1365-2133.1996.tb15664.x
Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis
G. Weinstein (1996)
10.1111/j.1365-2230.1992.tb02523.x
Topical application of 13‐cis‐retinoic acid in the treatment of chronic plaque psoriasis
R. Bischoff (1992)
10.1016/S0190-9622(98)70008-8
Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
M. Lebwohl (1998)
10.1111/1523-1747.EP12541294
Augmentation of oral methoxsalen-photochemotherapy with an oral retinoic acid derivative.
P. Fritsch (1978)
10.1007/978-3-642-81412-9_35
Neuere Entwicklungen in der Dermatologie
O. Braun-Falco (1979)
10.1111/j.1365-2133.1996.tb15663.x
Early clinical development of tazarotene
R. Marks (1996)
10.1007/BF00412699
Orale Behandlung mit Tretinoin
G. Plewig (2004)
10.1111/j.1365-2133.1996.tb15661.x
Oral retinoids—efficacy and toxicity in psoriasis
H. Gollnick (1996)
10.1007/BF00372055
The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin
G. Wozel (2004)
Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer.
M. Duvic (2000)
10.1046/j.1365-2133.1999.140S54024.x
The role of tazarotene in the treatment of psoriasis
Marks (1999)
Retinoid metabolism in the skin.
T. Roos (1998)
10.1016/S0190-9622(97)70216-0
Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect.
G. Weinstein (1997)
10.1016/S0190-9622(86)70244-2
Selected therapeutic applications of topical tretinoin.
A. A. Haas (1986)
Semantic Scholar Logo Some data provided by SemanticScholar